Equities not available in your region
CRNX icon

Crinetics Pharmaceuticals (CRNX)

NASDAQ

$ 83,47

$ 41,46 (

+98,67 %

)

1D
5D
1M
6M
1Y
5Y
After hours

CRNX: $ 83,47 / ₿ 0.0013 BTC / 131178 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$ 42,02
$ 25,83 - $ 57,99
8,80 Mrd. $
12.15
$ 83,58
$ 80.950.710,58
105,44 Mio.
$ 83,46 - $ 83,55
$ 83,43 - $ 83,59
Yes

What is Crinetics Pharmaceuticals (CRNX)?

Crinetics Pharmaceuticals Inc ist ein Pharmaunternehmen im kommerziellen Stadium, das sich auf die Entdeckung, Entwicklung und Kommerzialisierung neuartiger Therapeutika für seltene endokrine Erkrankungen und endokrin-assoziierte Tumoren konzentriert. Sein Hauptprodukt, Palsonify (Paltusotine), ist eine einmal täglich einzunehmende orale Behandlung, die von der FDA für Erwachsene mit Akromegalie zugelassen wurde, die unzureichend auf eine Operation angesprochen haben und/oder für die eine Operation keine Option ist. Darüber hinaus umfasst die Entwicklungspipeline des Unternehmens mehrere Programme, darunter einen klinischen Prüfkandidaten im Spätstadium, Atumelnant, der derzeit für CAH und ADCS entwickelt wird, und CRN09682, einen NDC-Kandidaten, der zur Behandlung von SST2-exprimierenden NETs und anderen SST2-exprimierenden soliden Tumoren entwickelt wird.

The Crinetics Pharmaceuticals (CRNX) stock price has been rising

The Crinetics Pharmaceuticals, Inc. Common Stock (CRNX) stock after-hours price today is $ 83,47, reflecting a +98,67 % after-hours move since the market last closed. The company’s market capitalization stands at 8,80 Mrd. $, with a daily trading volume of 80,95 Mio. $ shares. For investors tracking price trends, Crinetics Pharmaceuticals, Inc. Common Stock stock has ranged between $ 83,43 and $ 83,59 today. The previous closing price was $ 42,02.

Get started with Crinetics Pharmaceuticals (CRNX)

Ready to get started? Follow the steps below, or read our guide on how to buy Crinetics Pharmaceuticals stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy CRNX

Search for CRNX in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy CRNX.

CRNX FAQs

CRNX is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

CRNX is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Crinetics Pharmaceuticals, Inc. Common Stock (CRNX) has traded between a low of $ 25,83 and a high of $ 57,99.

CRNX is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Crinetics Pharmaceuticals? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
CRNX icon
CRNX

Only available to USA clients through the Kraken app
or Kraken Pro.

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

NCNCF icon

NCNCF

AFMDQ icon

AFMDQ

NCRA icon

NCRA

PFSA icon

PFSA

Top losers

Compare the worst-performing stocks of 
the day

YOTAR icon

YOTAR

FATPQ icon

FATPQ

CPTWF icon
KUKEY icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.